2014

Reproductive Medicine Associates of New Jersey Offers New Fertility Checklist to Help Patients Navigate Early Infertility Diagnosis and Treatment Options In Honor of National Infertility Awareness Week, RMANJ Supports Hopeful Parents with Important Information about Early Diagnosis and Treatments like IVF, PGD and Single Embryo Transfer

BASKING RIDGE, N.J., April 21, 2014 /PRNewswire/ -- With over seven million men and women in the United States impacted by infertility, information about early diagnosis and various infertility treatment options like in vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and comprehensive chromosome screening (CCS) can offer help to many patients looking to overcome infertility.

In observance of National Infertility Awareness Week, April 20-26, Reproductive Medicine Associates of New Jersey (RMANJ) has launched two new informational resources for prospective parents facing the challenges of infertility. MyFertilityChecklist.com is an interactive quiz that asks critical questions and provides important facts about when to seek the help of a reproductive endocrinologist for infertility care.

"If someone has been trying to get pregnant for 6-12 months without success and are approximately 35 years of age, they shouldn't wait to make that first call to a specialist," offered Dr. Shefali Shastri from RMANJ Somerset. "Information is power, so hopefully a resource like MyFertilityChecklist.com can help those patients who are Googling 'infertility,' right now."

In addition to the website, RMANJ is offering a free companion brochure that also provides helpful questions for patients to ask when looking for state of the art infertility care. The brochure can be downloaded at MyFertilityChecklist.com and www.RMANJ.com. RMANJ has also launched a series of infographics covering various topics related to infertility including:

"There are nearly 50 IVF centers in the New York-New Jersey area alone and the treatments offered can vary widely. So choosing the right place can be hard for patients new to infertility," commented Dr. Eric J. Forman from RMANJ Morristown. "Patients need to be aware that new options like CCS have been demonstrated to improve IVF delivery rates and single embryo transfer can provide high delivery rates but with fewer complications from twins and multiples," added Dr. Forman.

Visit MyFertilityChecklist.com to take the quiz and see if it might be time to talk to a reproductive specialist. Visit MyFertilityChecklist.com or www.RMANJ.com to download the free companion brochure with important questions to ask about your infertility care.

About Reproductive Medicine Associates of New Jersey 
Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS). Other centers have attempted similar testing methods, however RMANJ is one of the foremost fertility centers in the world to have developed a system of unprecedented accuracy and validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer.

With IVF delivery rates well above the National average (www.sart.org), the fertility experts at RMANJ have helped bring more than 30,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Rutgers Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit www.RMANJ.com.

SOURCE Reproductive Medicine Associates of New Jersey



RELATED LINKS
http://www.rmanj.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.